who shouldn't take glp 1 drugs GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1 Medications for Weight Loss:
Description
How this compares to Lilly and Novo Nordisk
Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated
This supports that pharmacies are permitted to compound GLP-1 drugs under section 503A of the Act, provided they adhere to specific conditions outlined by the FDA
Not intended to replace lifestyle habits
